ValueAct returns to Valeant board, plans to raise stake

(Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

from Reuters: Business News http://ift.tt/1n2deeE